Sign Up Now! Last night. I maxim a commercial representing an over-the-counter sleep aid. It promised to help me fall asleep quickly and to stay asleep waking refreshed the attached day.

It touted a breakthrough system of dual release -- the quick-release portion championing rapid relief and then the time-released component for a full night"s sleep. We"ve all seen these commercials, bagatelle surprising here.

What did fabricate me "tsk" was the last comment, "Now you can rest through the night without drugs." Huh? Whether this isn"t a drug, then what is? This is misleading to say the least and a bit dangerous.

It is, unfortunately, frequent for mankind to disconcert various appellation -- drug, medication medicine, prescription, over the counter, herbal remedy, dietary supplement -- rational that some words inherently mean a matter is safe.

These misconceptions are knowingly played up by marketing campaigns so I thought it would be helpful to define these words. What is a drug? A factor of The New York Period Company.

From http://bipolar.about.com/b/2008/02/01/what-is-a-drug.htm

If you blameless lowered your cholesterol, you could reduce your risk of a heart attack or stroke. Drug companies have done their best to deposit you focused on medications that bring cholesterol levels down. Turn on TV or open a periodical and you are likely to see an ad featuring Dr. Robert Jarvik, known as the inventor of the artificial heart.

He promotes Lipitor to discount cholesterol, and he has been wildly successful. The company brags that its statin-type medication has been prescribed to more than 26 million Americans. Lipitor earned its manufacturer and than $13 billion in 2006. Lipitor is not alone. Millions of Americans take cholesterol-lowering drugs like Crestor, Mevacor, Pravachol, Vytorin, Zocor and Zetia.

But perplexing new information have many patients confused. Headlines recently announced the results of a study comparing Vytorin, which contains both Zetia (ezetimibe) and Zocor (simvastatin), to Zocor alone.

Although Vytorin lowered bad LDL cholesterol 17 percent deeper than Zocor, the combination pill did not reduce dangerous plaque buildup in neck arteries. The patients on Vytorin may much have had slightly more plaque buildup. Cleveland Clinic cardiologist Steven Nissen was stunned by the consequence and called on his colleagues to reconsider routine use of Zetia or Vytorin as first-line treatments.

In 2006, 18 million prescriptions were written for Vytorin and 14 million championing Zetia.

Lowering cholesterol, especially bad LDL cholesterol, is assumed to be the Holy Grail representing preventing atherosclerosis and cardiovascular events.

But an earlier study of a novel medication called torcetrapib that lowers LDL and raises good HDL cholesterol was abandoned when patients taking the medicine in truth had aggrandized heart attacks and strokes. The new announce of Vytorin suggests that reducing LDL numbers may not be enough.

Even for tried-and-true cholesterol-lowering drugs, the benefit for any given especial may be smaller than people imagine. Lipitor, for example, has been shown in studies to prevent heart attacks.

Media ads capitalize on this, announcing that Lipitor cuts back the risk of affection attack by 36 percent. There is an asterisk coterminous to that number, however, and here is the fine print: That intend in a blimp clinical study, 3 percent of patients bewitching a sugar pill or placebo had a heart attack compared to 2 percent of patients taking Lipitor."

See Business Week, Jan. 17, 2008.)

In other words, whether you had 100 humans fascinating Lipitor and another 100 people taking an inactive placebo, there would be one less heart attack after several years amid the folks on Lipitor. That certainly matters a great deal if you are the one who was spared.

But if you are lone of the other 99, the cost and risk of side effects may seem high. No one should stop taking cholesterol-lowering medication without medical supervision, but cholesterol is not the only thing that matters. Physicians have known for decades that there are more than 200 risk ingredient for heart disease (New Great britain Journal of Medicine, Nov.

14, 2002). Inflammation, stress, hostility, depression and high triglycerides are just a few of the other contributors to heart disease. Focusing on cholesterol alone could be a big mistake.

Q. We tried a treatment from your path for nighttime stump cramps. My husband used to get them frequently and would have to walk them elsewhere while in pain.

He read that captivating mustard would alleviate them, so he tried it. At once when he gets pin cramps at night, he takes his mustard and they hardihood away quickly. He hang on to a few identical packets of mustard in the bedroom.

From http://chron.com/disp/story.mpl/life/dailycols/5489595.html

May 2006 :

Buy wager issue Why Scientists Shouldn't Be Surprised by the Popularity of Intelligent Design Point of view from Psych The leading obstacle standing in the pathway of the public's acceptance of evolutionary belief is not a want of average sense.

Instead, it is the public's erroneous assumption that customary sense is a dependable guide to evaluating the natural world. SCOTT O. LILIENFELD The growing regard of intelligent mould (ID) has left most scientists baffled, even exasperated.

It pits only idea backed next to tens of thousands of peer-reviewed articles and in harmony with multiple lines of converging genetic, physiological, and paleontological evidence against an armchair conjecture that has flown under the radar of peer review and has yet to generate a single confirmed scientific prediction.

Whether the contest were a boxing match, the referee would surely have stopped the fight seconds after the breach bell.

In a 2005 Gallup poll, 34 percent of Americans said they believed that Darwinian theory was false and 31 percent favoured ID as an explanation championing the development of species. As of this writing, at least forty states are in view of initiatives to include ID in public academy branch curricula.

Echoing the vocabulary of ID advocates, these standards refer to unexplained gaps in the fossil record and other purported challenges to the scientific stature of this theory. Shortly after this article was written, U.S. Community Justice John Jones ruled that ID could not be taught as an alternative to Darwinian theory in Dover, Pennsylvania, public schools.

It is too ahead of time to tell whether this ruling will induce popular support for ID across the country.) In response to such developments, many scientists have expressed disdain-even ridicule-for believers in ID.

Nobel Liking winner James D.

Watson, co-discoverer of the structure of DNA, was quoted recently in The Advanced York Spell as saying that only people who "put their common sense on hold" doubt evolutionary theory (Wade 2005).

Of course, much of the resistence to Darwinian theory is theological, and media coverage of ID proponents has accorded nearly exclusive emphasis to the intimate connection between ID and fundamentalist Christianity. Nevertheless, religion doesn't tell the whole story. The other reason for the public's embrace of bright design is its compatibility with intuition.

Contra Watson, it is Darwinian evolution, not ID, that is glaringly inconsistent with general sense. Political commentator Patrick J. Buchanan's (2005) recent expression are illustrative in this regard.

Indeed, from the vantage point of commonplace intuition, it is far more plausible to believe that complex organic shape alike the peacock's tail and elephant's trunk were shaped by a teleological force than by purposeless processes of mutation and natural choice operating above millions of years.

To many laypeople, the latter explanation sound hopelessly farfetched. If an alien visiting the earth were to go on upon these faces, they ask, would it regard them as the upshot of designed design or of unguided physical processes? The answer is obvious.

The foremost obstacle standing in the way of the public's acceptance of evolutionary theory is not a sparsity of daily sense.

From http://csicop.org/si/2006-03/intelligent-design.html